Similarly, KMD-5is restore expression of KMT2D- and CREBBP-regulated genes in KMT2D-mutant lymphomas, suggesting that these agents may have similar effects in the immune system (Heward J. A. et al., 2021). Here, KMT2D is linked to lymphoma.